Tomasz Franciszek Baran
Corporate Officer/Principal chez POLI BANK
Profil
Tomasz Franciszek Baran is currently the Vice Chairman-Management Board at Polski Bank Komorek Macierzystych SA since 2020.
He is also the Director at Stemlab sa and the Chief Commercial Officer at Vita 34 AG since 2022.
Previously, he served as the Chief Executive Officer at Famicordtx SA. He also held positions at Pliva Krakow Sa as Manager-Regional Sales & Product from 1998 to 2004, Astrazeneca Pharma Poland SP zoo as Manager-Marketing & Group Manager-Product from 2004 to 2008, and Stiefel Polska SP zoo as Marketing Manager from 2008 to 2009.
He has also worked as a Marketing Manager at GlaxoSmithKline Pharmaceuticals SA. Mr. Franciszek Baran holds an MBA from the University of Quebec and the Warsaw School of Economics.
He completed his undergraduate degree at the Medical University of Lublin in 1997.
Postes actifs de Tomasz Franciszek Baran
| Sociétés | Poste | Début |
|---|---|---|
| POLI BANK | Corporate Officer/Principal | 01/01/2012 |
| VITA 34 AG | Sales & Marketing | 22/03/2022 |
Stemlab sa
 Stemlab sa BiotechnologyHealth Technology Stemlab SA provides umbilical cord stem cell isolation and cryopreservation. It processes and stores umbilical cord blood and tissue for therapeutic applications. The company was founded by André Rodrigues de Abreu Gomes, Raúl Morais dos Santos, Luís Gomes, Gonçalo Castelo-Branco, Daniel Taborda, and Alexandra Mendes in July 2003 and is headquartered in Cantanhede, Portugal. | Director/Board Member | - |
Anciens postes connus de Tomasz Franciszek Baran
| Sociétés | Poste | Fin |
|---|---|---|
| Stiefel Polska SP zoo | Corporate Officer/Principal | 01/01/2009 |
| Astrazeneca Pharma Poland SP zoo | Sales & Marketing | 01/01/2008 |
Pliva Krakow Sa
 Pliva Krakow Sa Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Pliva Krakow Sa is a Polish pharmaceutical manufacturing company. The private company is based in Krakow, Poland. | Sales & Marketing | 01/01/2004 |
| Famicordtx SA | Chief Executive Officer | - |
Glaxosmithkline Pharmaceuticals SA
 Glaxosmithkline Pharmaceuticals SA Pharmaceuticals: GenericHealth Technology Part of GSK Plc, GlaxoSmithKline Pharmaceuticals SA is a Polish company that manufactures drugs and vaccines. The private company is based in Poznan, Poland. | Sales & Marketing | - |
Formation de Tomasz Franciszek Baran
| University of Quebec | Masters Business Admin |
| Warsaw School of Economics | Masters Business Admin |
| Medical University of Lublin | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VITA 34 AG | Health Technology |
| Entreprise privées | 7 |
|---|---|
Pliva Krakow Sa
Pliva Krakow Sa Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Pliva Krakow Sa is a Polish pharmaceutical manufacturing company. The private company is based in Krakow, Poland. | Health Technology |
Stemlab sa
Stemlab sa BiotechnologyHealth Technology Stemlab SA provides umbilical cord stem cell isolation and cryopreservation. It processes and stores umbilical cord blood and tissue for therapeutic applications. The company was founded by André Rodrigues de Abreu Gomes, Raúl Morais dos Santos, Luís Gomes, Gonçalo Castelo-Branco, Daniel Taborda, and Alexandra Mendes in July 2003 and is headquartered in Cantanhede, Portugal. | Health Technology |
Polski Bank Komorek Macierzystych SA
 Polski Bank Komorek Macierzystych SA Other TransportationTransportation Polski Bank Komorek Macierzystych SA engages in the provision of stem cell collection services. The firm also offers stem cells transplantation. It operates through the following segments: B2C Afterbirth Tissue Banking Services (B2C), B2B Afterbirth Tissue Banking Services (B2B), and R&D Activities. The B2C segment refers to the services consisting in the preparation and storage of human biological material for individual retail customers. The B2B segment pertains to the services consisting in the preparation and/or storage of biological materials for business partners. The R&D Activities segment comprises of the group's research and development activities. The company was founded in 2002 and is headquartered in Warsaw, Poland. | Transportation |
| Astrazeneca Pharma Poland SP zoo | |
| Stiefel Polska SP zoo | |
| Famicordtx SA | |
Glaxosmithkline Pharmaceuticals SA
Glaxosmithkline Pharmaceuticals SA Pharmaceuticals: GenericHealth Technology Part of GSK Plc, GlaxoSmithKline Pharmaceuticals SA is a Polish company that manufactures drugs and vaccines. The private company is based in Poznan, Poland. | Health Technology |
